BC
BNTX icon

Bayforest Capital’s BioNTech BNTX Stock Holding History

Bayforest Capital’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$116K Buy
+1,181
New +$115K 0.17% 215
2026
Q2 		– Sell
-1,275
Closed -$113K – 975
2026
Q1 		$113K Sell
1,275
-2,281
-64% -$234K 0.13% 317
2025
Q4 		$339K Buy
+3,556
New +$358K 0.25% 95
2025
Q1 		– Sell
-443
Closed -$50.5K – 742
2024
Q4 		$50.5K Buy
+443
New +$50.6K 0.06% 470

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LBP AM
LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Bayforest Capital's BNTX Position: Q3 2026 in Review

Bayforest Capital opened a new position in BioNTech (BNTX) in Q3 2026: 1,181 shares worth $116K. The stake represents 0.17% of the portfolio and ranks #215 among its holdings. This is a return to the name: Bayforest Capital previously reported a position in BNTX as recently as Q1 2026.

Bayforest Capital first reported a position in BNTX in Q4 2024 and has held it in 4 quarters since. The position peaked at $339K in Q4 2025. 144 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

  • Bayforest Capital held 1,181 shares of BioNTech worth $116K as of Q3 2026.
  • BioNTech was a new Bayforest Capital position in Q3 2026.
  • BioNTech made up 0.17% of Bayforest Capital's portfolio in Q3 2026, its #215 holding.
  • Bayforest Capital first reported a position in BioNTech in Q4 2024 and has held it in 4 quarters since.
  • Bayforest Capital's BioNTech position peaked at $339K in Q4 2025.
  • 144 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Bayforest Capital's 13F filing for Q3 2026, filed 3 Nov 2026.